Global Influenza Vaccine Competitive Landscape Professional Research Report 2024

Research Summary

An influenza vaccine, commonly known as the flu shot, is a preventive medical treatment designed to protect individuals from infection by the influenza virus. Influenza vaccines contain inactivated or weakened strains of the influenza virus or its components, stimulating the immune system to develop antibodies. These antibodies can recognize and neutralize the virus when the body encounters it, reducing the severity of illness and the risk of complications if exposed to the flu. Influenza vaccines are administered annually, typically before the flu season, and are especially recommended for individuals at higher risk of complications, such as the elderly, young children, pregnant women, and people with certain medical conditions. Mass vaccination programs have contributed to the reduction of flu-related illnesses and hospitalizations, making the influenza vaccine a crucial tool in public health efforts to prevent the spread of the flu.

According to DIResearch's in-depth investigation and research, the global Influenza Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Influenza Vaccine. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Influenza Vaccine market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Influenza Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Influenza Vaccine Include:

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Influenza Vaccine Product Segment Include:

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Influenza Vaccine Product Application Include:

6 Months to 3 Years

? 1/4 ? 3 Years

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Influenza Vaccine Industry PESTEL Analysis

Chapter 3: Global Influenza Vaccine Industry Porter's Five Forces Analysis

Chapter 4: Global Influenza Vaccine Major Regional Market Size and Forecast Analysis

Chapter 5: Global Influenza Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Influenza Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Influenza Vaccine Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Influenza Vaccine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Influenza Vaccine Product by Type

1.2.1 Global Influenza Vaccine Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Influenza Vaccine Product by Application

1.3.1 Global Influenza Vaccine Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 6 Months to 3 Years

1.3.3 ? 1/4 ? 3 Years

1.4 Global Influenza Vaccine Market Revenue Analysis (2019-2030)

1.5 Influenza Vaccine Market Development Status and Trends

1.5.1 Influenza Vaccine Industry Development Status Analysis

1.5.2 Influenza Vaccine Industry Development Trends Analysis

2 Influenza Vaccine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Influenza Vaccine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Influenza Vaccine Market Analysis by Regions

4.1 Influenza Vaccine Overall Market: 2023 VS 2024 VS 2030

4.2 Global Influenza Vaccine Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Influenza Vaccine Revenue and Market Share by Region (2019-2024)

4.2.2 Global Influenza Vaccine Revenue Forecast by Region (2025-2030)

5 Global Influenza Vaccine Market Size by Type and Application

5.1 Global Influenza Vaccine Market Size by Type

5.2 Global Influenza Vaccine Market Size by Application

6 North America

6.1 North America Influenza Vaccine Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Influenza Vaccine Market Size by Type

6.4 North America Influenza Vaccine Market Size by Application

6.5 North America Influenza Vaccine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Influenza Vaccine Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Influenza Vaccine Market Size by Type

7.4 Europe Influenza Vaccine Market Size by Application

7.5 Europe Influenza Vaccine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Influenza Vaccine Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Influenza Vaccine Market Size by Type

8.4 China Influenza Vaccine Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Influenza Vaccine Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Influenza Vaccine Market Size by Type

9.4 APAC (excl. China) Influenza Vaccine Market Size by Application

9.5 APAC (excl. China) Influenza Vaccine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Influenza Vaccine Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Influenza Vaccine Market Size by Type

10.4 Latin America Influenza Vaccine Market Size by Application

10.5 Latin America Influenza Vaccine Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Influenza Vaccine Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Influenza Vaccine Market Size by Type

11.4 Middle East & Africa Influenza Vaccine Market Size by Application

11.5 Middle East & Africa Influenza Vaccine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Influenza Vaccine Market Revenue by Key Manufacturers (2020-2024)

12.2 Influenza Vaccine Competitive Landscape Analysis and Market Dynamic

12.2.1 Influenza Vaccine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Sanofi

13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Sanofi Influenza Vaccine Product Portfolio

13.1.3 Sanofi Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 CSL

13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 CSL Influenza Vaccine Product Portfolio

13.2.3 CSL Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 GSK

13.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 GSK Influenza Vaccine Product Portfolio

13.3.3 GSK Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Viatris

13.4.1 Viatris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Viatris Influenza Vaccine Product Portfolio

13.4.3 Viatris Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 AstraZeneca

13.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 AstraZeneca Influenza Vaccine Product Portfolio

13.5.3 AstraZeneca Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Hualan Bio

13.6.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Hualan Bio Influenza Vaccine Product Portfolio

13.6.3 Hualan Bio Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Changchun Institute of Biological

13.7.1 Changchun Institute of Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Changchun Institute of Biological Influenza Vaccine Product Portfolio

13.7.3 Changchun Institute of Biological Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Sinovac

13.8.1 Sinovac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Sinovac Influenza Vaccine Product Portfolio

13.8.3 Sinovac Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 BCHT

13.9.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 BCHT Influenza Vaccine Product Portfolio

13.9.3 BCHT Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Jiangsu GDK

13.10.1 Jiangsu GDK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Jiangsu GDK Influenza Vaccine Product Portfolio

13.10.3 Jiangsu GDK Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 KM Biologics

13.11.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 KM Biologics Influenza Vaccine Product Portfolio

13.11.3 KM Biologics Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Influenza Vaccine Industry Chain Analysis

14.2 Influenza Vaccine Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Influenza Vaccine Typical Downstream Customers

14.4 Influenza Vaccine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support